Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000221080

Medchemexpress LLC 1-(1-(2-(piperidin-1-yl)acetyl)piperidin-4-yl)-5-(1-isopropyl-2-oxo-... | 2768712-71-4 | 99.9% | 461.60 g/mol | C27H35N5O2 | 5 MG
SDP

Catalog No. 5000221080
Encompass_Preferred

CDK9-IN-13 is a research-grade small-molecule inhibitor selective for cyclin-dependent kinase 9 (CDK9). It exhibits potent biochemical inhibition of CDK9 (IC50 <3 nM), displays short half-lives in rodents, and is supplied at high purity for biochemical and cellular studies.

  • Potent CDK9 inhibition (IC50 <3 nM)
  • Selective kinase profile with reduced off-target activity
  • High purity (99.94%) suitable for research assays
  • Molecular weight 461.60 g/mol; formula C27H35N5O2
  • Available in small mg quantities for screening and validation

Catalog No. 50-002-21080 Supplier Medchemexpress LLC Supplier No. HY1399805MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

CDK9-IN-13 is a research-grade small-molecule inhibitor selective for cyclin-dependent kinase 9 (CDK9). It exhibits potent biochemical inhibition of CDK9 (IC50 <3 nM), displays short half-lives in rodents, and is supplied at high purity for biochemical and cellular studies.

  • Potent CDK9 inhibition (IC50 <3 nM)
  • Selective kinase profile with reduced off-target activity
  • High purity (99.94%) suitable for research assays
  • Molecular weight 461.60 g/mol; formula C27H35N5O2
  • Available in small mg quantities for screening and validation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.